Diane Ethier

Author PubWeight™ 11.00^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile.	J Biol Chem	2004	1.29
2	Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.	Bioorg Med Chem Lett	2005	1.15
3	Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.	Bioorg Med Chem Lett	2007	1.05
4	Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.	Bioorg Med Chem Lett	2009	0.93
5	Substituted coumarins as potent 5-lipoxygenase inhibitors.	Bioorg Med Chem Lett	2006	0.93
6	Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.	J Biol Chem	2007	0.92
7	In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.	Mol Pharmacol	2008	0.86
8	5-oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte/macrophage colony-stimulating factor from monocytes.	J Biol Chem	2004	0.81
9	Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.	Bioorg Med Chem Lett	2009	0.80
10	Trisubstituted ureas as potent and selective mPGES-1 inhibitors.	Bioorg Med Chem Lett	2011	0.79
11	Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors.	Bioorg Med Chem Lett	2003	0.78
12	An automated multistep high-throughput screening assay for the identification of lead inhibitors of the inducible enzyme mPGES-1.	J Biomol Screen	2005	0.75
13	Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.	Bioorg Med Chem Lett	2005	0.75